I, DIANNA PROSSER, Assistant Secretary (Acting), Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health and Aged Care, make this Determination under subsection 99ADB (6B) of the National Health Act 1953.

Dated       24th    August 2016

_____________________________________

DIANNA PROSSER

Assistant Secretary (Acting)

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health

1 Name of Determination

 (1) This Determination is the National Health (Originator Brand) Amendment Determination 2016 (No. 6).

(2) This Determination may also be cited as PB 79 of 2016.

2 Commencement

  This Determination commences on 1 September 2016.

3 Amendments to PB 100 of 2015

  Schedule 1 amends the National Health (Originator Brand) Determination 2015 (PB 100 of 2015).

Schedule 1 Amendments

(section 3)

[1] Schedule 1, table item 154 (entry for mometasone)

substitute: